10-Q Filing

GUIDED THERAPEUTICS INC CIK: 924515 Q3 2013

Filing Information

Form Type	10-Q
Accession Number	`0001121781-13-000411`
Period End Date	20130930
Filing Date	20131113
Fiscal Year	2013
Fiscal Period	Q3
XBRL Instance	gthp-20130930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 78 Income Statement 72 Cash Flow Statement 62

Balance Sheet 78 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$12.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$400.00K	USD	Point-in-time
Accounts receivable, net of allowance	`AccountsAndNotesReceivableNet`	$18.00K	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$2.61M	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 and $12 at September 30, 2013 and December 31, 2012	`AccountsReceivableNet`	$112.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$52.00K	USD	Point-in-time
Inventory, net of reserves	`InventoryFinishedGoodsNetOfReserves`	$44.00K	USD	Point-in-time
Accounts receivable, net of allowance for doubtful accounts of $18 and $12 at September 30, 2013 and December 31, 2012	`AccountsReceivableNet`	$107.00K	USD	Point-in-time
Inventory, net of reserves of $99 and $52, at September 30, 2013 and December 31, 2012	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$524.00K	USD	Point-in-time
Inventory, net of reserves of $99 and $52, at September 30, 2013 and December 31, 2012	`InventoryNetOfReservesOf64And0AtDecember312011And2010Respectively`	$810.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$185.00K	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$198.00K	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Series B convertible preferred stock par value	`PreferredStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.87M	USD	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Series B convertible preferred stock shares authorized	`PreferredStockSharesAuthorized`	3,000.00	shares	Point-in-time
Total current assets	`AssetsCurrent`	$1.51M	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	2,457.00	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.27M	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$1.03M	USD	Point-in-time
Series B convertible preferred stock, Issued	`PreferredStockSharesIssued`	2,527.00	shares	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	2,527.00	shares	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$394.00K	USD	Point-in-time
Other assets	`AssetsNoncurrentOtherThanNoncurrentInvestmentsAndPropertyPlantAndEquipment`	$331.00K	USD	Point-in-time
Series B convertible preferred stock, Outstanding	`PreferredStockSharesOutstanding`	2,457.00	shares	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.60M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	$0.00	USD	Point-in-time
Total noncurrent assets	`AssetsNoncurrent`	$1.42M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$2.93M	USD	Point-in-time
Common stock, Authorized	`CommonStockSharesAuthorized`	145,000.00	shares	Point-in-time
TOTAL ASSETS	`Assets`	$3.48M	USD	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	62.28M	shares	Point-in-time
Common stock, Issued	`CommonStockSharesIssued`	66.30M	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$79.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	62.28M	shares	Point-in-time
Short-term notes payable	`ShorttermNotesPayable`	$70.00K	USD	Point-in-time
Common stock, outstanding	`CommonStockSharesOutstanding`	66.30M	shares	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$107.00K	USD	Point-in-time
Current portion of long-term note payable	`ShortTermBorrowings`	$4.00K	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	-	USD	Point-in-time
Notes payable - past due	`NotesPayablePastDue`	$419.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$765.00K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$822.00K	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$1.04M	USD	Point-in-time
Accrued liabilities	`AccruedLiabilitiesCurrent`	$575.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$40.00K	USD	Point-in-time
Deferred revenue	`DeferredRevenue`	$37.00K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.35M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$1.61M	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	$663.00K	USD	Point-in-time
Warrants, at fair value	`WarrantsNotSettleableInCashFairValueDisclosure`	-	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	$135.00K	USD	Point-in-time
Long-term debt payable, less current portion	`LongTermDebtNoncurrent`	-	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	$798.00K	USD	Point-in-time
Total long-term liabilities	`LiabilitiesNoncurrent`	-	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$2.35M	USD	Point-in-time
TOTAL LIABILITIES	`Liabilities`	$2.41M	USD	Point-in-time
COMMITMENTS & CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
COMMITMENTS & CONTINGENCIES	`CommitmentsAndContingencies`	-	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 2,457 and 2,527 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	-	USD	Point-in-time
Series B convertible preferred stock, $.001 par value; 3,000 shares authorized, 2,457 and 2,527 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	`ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue`	$1.30M	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 66,303,996 and 62,282 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$62.00K	USD	Point-in-time
Common stock, $.001 Par value; 145,000 shares authorized, 66,303,996 and 62,282 shares issued and outstanding as of September 30, 2013 and December 31, 2012, respectively	`CommonStockValue`	$66.00K	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$93.27M	USD	Point-in-time
Additional paid-in capital	`AdditionalPaidInCapital`	$97.56M	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$104.00K	USD	Point-in-time
Treasury stock, at cost	`TreasuryStockValue`	$132.00K	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-98.27M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-92.10M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$1.13M	USD	Point-in-time
TOTAL STOCKHOLDERS' EQUITY	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$522.00K	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$2.93M	USD	Point-in-time
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY	`LiabilitiesAndStockholdersEquity`	$3.48M	USD	Point-in-time

Income Statement 72 line items

Line Item	Tag	Value	Unit	Period
Contract and grant revenue	`Revenues`	$86.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$2.33M	USD	3 Qtrs
Contract and grant revenue	`Revenues`	$693.00K	USD	1 Quarter
Contract and grant revenue	`Revenues`	$474.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$72.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$43.00K	USD	1 Quarter
Sales - devices and disposables	`SalesDevicesAndDisposables`	$306.00K	USD	3 Qtrs
Sales - devices and disposables	`SalesDevicesAndDisposables`	$58.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$394.00K	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$55.00K	USD	1 Quarter
Cost of goods sold	`CostOfGoodsSold`	$130.00K	USD	3 Qtrs
Cost of goods sold	`CostOfGoodsSold`	$117.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-59.00K	USD	1 Quarter
Gross Loss	`GrossProfit`	$-58.00K	USD	3 Qtrs
Gross Loss	`GrossProfit`	$-88.00K	USD	3 Qtrs
Gross Loss	`GrossProfit`	$-12.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$787.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.40M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$596.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$2.24M	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$271.00K	USD	3 Qtrs
Sales and marketing	`SellingAndMarketingExpense`	$249.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$132.00K	USD	1 Quarter
Sales and marketing	`SellingAndMarketingExpense`	$608.00K	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$2.71M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$732.00K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$2.79M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$822.00K	USD	1 Quarter
Total	`OperatingExpenses`	$1.65M	USD	1 Quarter
Total	`OperatingExpenses`	$5.38M	USD	3 Qtrs
Total	`OperatingExpenses`	$1.67M	USD	1 Quarter
Total	`OperatingExpenses`	$5.64M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-3.11M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-1.64M	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-970.00K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-5.26M	USD	3 Qtrs
OTHER INCOME	`OtherIncome`	$289.00K	USD	3 Qtrs
OTHER INCOME	`OtherIncome`	-	USD	1 Quarter
OTHER INCOME	`OtherIncome`	-	USD	3 Qtrs
OTHER INCOME	`OtherIncome`	$213.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$52.00K	USD	3 Qtrs
INTEREST EXPENSE	`InterestExpense`	$11.00K	USD	1 Quarter
INTEREST EXPENSE	`InterestExpense`	$35.00K	USD	3 Qtrs
INTEREST EXPENSE	`InterestExpense`	$16.00K	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$5.00M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$1.44M	USD	1 Quarter
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$3.17M	USD	3 Qtrs
LOSS BEFORE INCOME TAXES	`LossBeforeIncomeTaxes`	$986.00K	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	3 Qtrs
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
PROVISION FOR INCOME TAXES	`IncomeTaxReconciliationOtherReconcilingItems`	-	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-3.17M	USD	3 Qtrs
NET LOSS	`NetIncomeLoss`	$-986.00K	USD	1 Quarter
NET LOSS	`NetIncomeLoss`	$-5.00M	USD	3 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	$-1.17M	USD	3 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	-	USD	3 Qtrs
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
PREFERRED STOCK DIVIDENDS	`PreferredStockDividendsIncomeStatementImpact`	-	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-986.00K	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-3.17M	USD	3 Qtrs
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-1.44M	USD	1 Quarter
NET LOSS ATTRIBUTABLE TO COMMON STOCKHOLDERS	`NetIncomeLossAvailableToCommonStockholdersBasic`	$-6.17M	USD	3 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.06	USD	3 Qtrs
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
BASIC AND DILUTED NET LOSS PER SHARE ATTRIBUTABLE TO COMMON STOCKHOLDERS	`EarningsPerShareBasicAndDiluted`	$-0.10	USD	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	65,212.00	shares	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	66,261.00	shares	1 Quarter
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	55,810.00	shares	3 Qtrs
WEIGHTED AVERAGE SHARES OUTSTANDING	`WeightedAverageNumberOfSharesOutstandingBasic`	60,827.00	shares	1 Quarter

Cash Flow Statement 62 line items

Line Item	Tag	Value	Unit	Period
Net loss	`NetIncomeLoss`	$-1.44M	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-3.17M	USD	3 Qtrs
Net loss	`NetIncomeLoss`	$-986.00K	USD	1 Quarter
Net loss	`NetIncomeLoss`	$-5.00M	USD	3 Qtrs
Bad debt expense (recovery)	`BadDebtRecovery`	$-8.00K	USD	3 Qtrs
Bad debt expense (recovery)	`BadDebtRecovery`	$7.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$258.00K	USD	3 Qtrs
Depreciation and amortization	`DepreciationAndAmortization`	$344.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$699.00K	USD	3 Qtrs
Stock based compensation	`ShareBasedCompensation`	$493.00K	USD	3 Qtrs
Warrants	`WarrantsExpense`	-	USD	3 Qtrs
Warrants	`WarrantsExpense`	$-210.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$-296.00K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$60.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$-11.00K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$59.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$-64.00K	USD	3 Qtrs
Other current assets	`IncreaseDecreaseInOtherCurrentAssets`	$12.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$57.00K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-62.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$129.00K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-3.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$9.00K	USD	3 Qtrs
Accrued liabilities	`IncreaseDecreaseInAccruedLiabilities`	$44.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$139.00K	USD	3 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$-64.00K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$544.00K	USD	3 Qtrs
Total adjustments	`AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities`	$1.05M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-2.12M	USD	3 Qtrs
Net cash used in operating activities	`NetCashProvidedByUsedInContinuingOperations`	$-4.46M	USD	3 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$496.00K	USD	3 Qtrs
Additions to fixed assets	`PaymentsToAcquirePropertyPlantAndEquipment`	$111.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-496.00K	USD	3 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-111.00K	USD	3 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	-	USD	3 Qtrs
Net proceeds from issuance of preferred stock and warrants	`ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants`	$2.21M	USD	3 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$1.92M	USD	3 Qtrs
Proceeds from options and warrants exercised	`ProceedsFromWarrantExercises`	$3.07M	USD	3 Qtrs
Proceeds from issuance of short-term notes payable	`ProceedsFromNotesPayable`	$115.00K	USD	3 Qtrs
Proceeds from issuance of short-term notes payable	`ProceedsFromNotesPayable`	-	USD	3 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$50.00K	USD	3 Qtrs
Payments on notes and loan payables	`PaymentsOfLoanCosts`	$320.00K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.02M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.92M	USD	3 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$409.00K	USD	3 Qtrs
NET CHANGE IN CASH AND CASH EQUIVALENTS	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-644.00K	USD	3 Qtrs
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$400.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, beginning of year	`CashAndCashEquivalentsAtCarryingValue`	$2.61M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$1.04M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$400.00K	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.20M	USD	Point-in-time
CASH AND CASH EQUIVALENTS, end of period	`CashAndCashEquivalentsAtCarryingValue`	$2.61M	USD	Point-in-time
Cash paid for Interest	`InterestPaid`	$12.00K	USD	3 Qtrs
Cash paid for Interest	`InterestPaid`	$11.00K	USD	3 Qtrs
Deemed dividends in the form of convertible warrants into common stock	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	-	USD	3 Qtrs
Deemed dividends in the form of convertible warrants into common stock	`DeemedDividendsInFormOfConvertibleWarrantsIntoCommonStock`	$2.65M	USD	3 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	$1.17M	USD	3 Qtrs
Deemed dividends on preferred stock	`DeemedDividendsOnPreferredStock`	-	USD	3 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$148.00K	USD	3 Qtrs
Issuance of common stock as board compensation	`IssuanceOfCommonStockAsBoardCompensation`	$463.00K	USD	3 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.